A2Z Cust2Mate Solutions Corp., a technology company, focuses on the development and commercialization of retail smart cart solutions for grocery stores and supermarkets in Israel and internationally. The company operates through three segments: Precision Metal Parts, Advanced Engineering, and Smart Carts. It offers Cust2Mate system, which incorporates a smart cart that automatically calculates the value of the customers purchases in their smart cart without having to unload and reload their purchases at a customer checkout point. The company also manufactures and sells precision metal parts; provides retail automation solutions; and develops Fuel Tank Inertia Capsule System technology (FTICS), a vehicle device cover for the military and civilian automotive industry. In addition, it provides maintenance services utilizing the application of advanced engineering capabilities to the military and security markets, as well as develops related products for the civilian and retail markets; container leasing services; and maintenance services for complex electronic systems and products. It serves its products to grocery stores, hardware stores, household essentials, do it yourself (DIY) retailers, discount stores, warehouse stores, convenience stores, drug stores, duty free shops, and similar outlets. The company was formerly known as A2Z Smart Technologies Corp. and changed its name to  A2Z Cust2Mate Solutions Corp. in August 2024. The company is headquartered in Vancouver, Canada.

A2Z Cust2Mate Solutions Corp.

AstraZeneca plc ($GB:AZN) announced an update on their ongoing clinical study. The ROSY-F roll-over study from AstraZeneca (AZN) aims to keep patie...

AstraZeneca Extends Fasenra’s Runway With New Long-Term Safety Study

AstraZeneca ($~AZN) announced an update on their ongoing clinical study. The ESPERANZA study, officially titled “External Control Arm Study for T-D...

ESPERANZA Update: Real-World Data Study Could Broaden AstraZeneca’s T-DXd Cancer Opportunity

RBC Capital analyst Leonid Timashev maintained a Buy rating on Jazz Pharmaceuticals on April 6 and set a price target of $195.00. The company’s sha...

RBC Capital Remains a Buy on Jazz Pharmaceuticals (JAZZ)

Northland Securities analyst maintained a Buy rating on A2Z Smart Technologies today and set a price target of $15.00. Currently, the analyst conse...

A2Z Smart Technologies (AZ) Gets a Buy from Northland Securities

UBS analyst Andrei Condrea maintained a Buy rating on EBRO FOODS today and set a price target of €21.70. According to TipRanks, Condrea is ranked #...

UBS Sticks to Its Buy Rating for EBRO FOODS (0NYH)

J.P. Morgan analyst Richard Vosser maintained a Buy rating on AstraZeneca today and set a price target of £160.00. According to TipRanks, Vosser is...

J.P. Morgan Reaffirms Their Buy Rating on AstraZeneca (AZN)

Austin, Texas, United States, April 6th, 2026, FinanceWire A2Z Cust2Mate Solutions Corp. (NASDAQ:AZ)&nbsp;announced a five-year strategic agreement...

A2Z Cust2Mate Solutions (NASDAQ: AZ) Secures $50M Smart Cart Deal With Carrefour Israel

In a report released yesterday, Rajan Sharma from Goldman Sachs maintained a Buy rating on AstraZeneca, with a price target of p16,600.00. The comp...

AstraZeneca (AZN) Receives a Buy from Goldman Sachs

AstraZeneca ($~AZN) announced an update on their ongoing clinical study. AstraZeneca (~AZN) has updated a Phase I clinical trial called “A Phase I ...

AstraZeneca Completes Early Obesity Trial for AZD6234, Nudging Long-Term Growth Hopes

President Donald Trump on Thursday signed an executive order to impose a 100% tariff on imported branded medicines (patented drugs and their active...

AZN, NVO, NVS: What Does Trump’s New 100% Tariff Mean for Pharma Giants?

The latest announcement is out from Azenta ( ($AZTA) ). Azenta, Inc. disclosed that a planned sale of the entire issued share capital of its subsid...

Azenta Faces Delay in B Medical Systems Divestiture

The latest announcement is out from CBL & Associates Properties ( ($CBL) ). On March 27, 2026, CBL & Associates Limited Partnership closed a $176 m...

CBL & Associates Completes Major Refinancing, Boosts Dividend

AstraZeneca plc ($GB:AZN) announced an update on their ongoing clinical study. AstraZeneca Tests Cancer Drug Mix for Safety and Drug Interactions T...

AstraZeneca’s New Cancer Combo Trial Signals Steady Progress in Antibody Drug Conjugates

In a report released today, Paul Howard CFA from Canaccord Genuity maintained a Buy rating on Antipa Minerals Limited, with a price target of A$1.2...

Canaccord Genuity Reaffirms Their Buy Rating on Antipa Minerals Limited (AZY)

Antipa Minerals Limited ( ($AU:AZY) ) just unveiled an update. Antipa Minerals has updated the Mineral Resource Estimate for its 100%-owned Minyari...

Antipa boosts Minyari resource to 3.6Moz gold equivalent, lifts confidence in key deposits

The latest update is out from A2Z Smart Technologies ( ($AZ) ). On March 31, 2026, A2Z Cust2Mate Solutions Corp. held its annual and special meetin...

A2Z Cust2Mate Shareholders Approve All Resolutions at March 31, 2026 Annual and Special Meeting

Goldman Sachs analyst James Yaro maintained a Sell rating on Lazard today and set a price target of $40.00. According to TipRanks, Yaro is a 4-star...

Lazard (LAZ) Receives a Sell from Goldman Sachs

The latest update is out from Plaza Centers N.V. ( ($PL:PLZ) ). Plaza Centers reported a sharply reduced operating loss of €0.6 million for 2025 ve...

Plaza Centers Narrows Operating Loss but Faces Acute Liquidity Strain and Casa Radio Legal Battle

There’s a lot to be optimistic about in the Technology sector as 3 analysts just weighed in on Tower (TSEM), Catapult Group International (CAZGF) a...

Analysts Offer Insights on Technology Companies: Tower (TSEM), Catapult Group International (OtherCAZGF) and Aeva Technologies (AEVA)

Mazda Limited ( ($IN:MAZDA) ) has provided an update. Mazda Limited has notified the Indian stock exchanges that its trading window for promoters, ...

Mazda Limited Announces Trading Window Closure Ahead of FY26 Results

Platzer Fastigheter Holding AB ( ($SE:PLAZ.B) ) just unveiled an update. Platzer Fastigheter has agreed a combined asset swap with the Port of Goth...

Platzer Reshapes Arendal Portfolio in SEK 684m Asset Swap with Port of Gothenburg

The latest announcement is out from Catapult Group International ( ($AU:CAT) ). Catapult Sports Ltd will release 463,334 fully paid ordinary shares...

Catapult Sports to Release Escrowed Shares Linked to SBG Acquisition

In a report released yesterday, Salim Syed from Mizuho Securities maintained a Buy rating on Maze Therapeutics, Inc., with a price target of $97.00...

Maze Therapeutics, Inc. (MAZE) Gets a Buy from Mizuho Securities

Azarga Metals ( ($TSE:AZR) ) just unveiled an update. Azarga Metals has closed an oversubscribed non-brokered private placement, raising gross proc...

Azarga Metals Raises $500,560 in Oversubscribed Placement and Hires Marketing Firm

Jefferies analyst Michael Leuchten maintained a Buy rating on AstraZeneca on March 27 and set a price target of p18,000.00. Leuchten covers the Hea...

AstraZeneca (AZN) Receives a Buy from Jefferies

Citi analyst Graham Parry maintained a Buy rating on AstraZeneca today and set a price target of £170.00. According to TipRanks, Parry is a 2-star ...

Citi Sticks to Its Buy Rating for AstraZeneca (AZN)

In a report released today, Chris Savage from Bell Potter maintained a Buy rating on Catapult Group International, with a price target of A$4.75. S...

Bell Potter Remains a Buy on Catapult Group International (CAZGF)

In a report released on March 27, Laurent Daure from Kepler Capital maintained a Buy rating on Capgemini SE, with a price target of €175.00. The co...

Kepler Capital  Sticks to Their Buy Rating for Capgemini SE (0HAZ)

In a report released today, Rami Katkhuda from LifeSci Capital maintained a Buy rating on Maze Therapeutics, Inc., with a price target of $57.00. K...

Maze Therapeutics, Inc. (MAZE) Gets a Buy from LifeSci Capital

Traders can read the latest stock market happenings in our daily wrap-up.


Morning News Wrap-Up: 3/27/26: Today’s Biggest Stock Market Stories

Atea ASA ( ($ATAZF) ) just unveiled an update. Atea ASA has continued to execute on its previously announced share buyback program, repurchasing 35...

Atea Increases Treasury Share Holdings Under Ongoing Buyback Program

J.P. Morgan analyst Richard Vosser maintained a Buy rating on AstraZeneca today and set a price target of £138.30. According to TipRanks, Vosser is...

J.P. Morgan Keeps Their Buy Rating on AstraZeneca (AZN)

UBS analyst Evan Karatzas maintained a Buy rating on Catapult Group International yesterday and set a price target of A$6.45. According to TipRanks...

UBS Remains a Buy on Catapult Group International (CAZGF)

Companies in the Healthcare sector have received a lot of coverage today as analysts weigh in on Maze Therapeutics, Inc. (MAZE), Azitra Inc (AZTR) ...

Analysts Conflicted on These Healthcare Names: Maze Therapeutics, Inc. (MAZE), Azitra Inc (AZTR) and Arrowhead Pharmaceuticals (ARWR)

Canary Gold Corp. ( ($TSE:BRAZ) ) has provided an announcement. Canary Gold Corp. has confirmed it will meet its second‑anniversary obligations und...

Canary Gold Extends Exploration Spend Deadline, Confirms Rio Madeira Payment and Share Issuance

AstraZeneca plc ($GB:AZN) announced an update on their ongoing clinical study. The CHOICE study, formally titled “A Cross-sectional Survey-based St...

AstraZeneca’s CHOICE Survey Targets Real-World Drivers of EGFR-TKI Use in China

AstraZeneca ($~AZN) announced an update on their ongoing clinical study. The study, titled “Clinical Observational Study of Remote, Non-invasive, M...

AstraZeneca Completes Heart Failure Wearable Study, Boosting Its Digital Health Edge

Avanza Bank Holding AB ( ($SE:AZA) ) has issued an announcement. Avanza Bank Holding AB has issued SEK 500 million in Additional Tier 1 capital to ...

Avanza Raises SEK 500 Million in AT1 Issue to Bolster Capital Structure

The latest update is out from Ratos AB ( ($SE:RATO.B) ). Ratos’ Annual General Meeting in Stockholm approved the 2025 accounts, discharged the boar...

Ratos AGM Backs Dividend, Incentive Plan and Expanded Deal-Making Mandates

There’s a lot to be optimistic about in the Healthcare sector as 3 analysts just weighed in on Alnylam Pharma (ALNY), Biomea Fusion (BMEA) and Maze...

Analysts Are Bullish on These Healthcare Stocks: Alnylam Pharma (ALNY), Biomea Fusion (BMEA)

Catapult Group International ( ($AU:CAT) ) has shared an update. State Street Corporation and several of its asset management subsidiaries have fil...

State Street Entities Exit Substantial Holding in Catapult Sports

Canary Gold Corp. ( ($TSE:BRAZ) ) has provided an announcement. Canary Gold Corp. reported encouraging early drilling results at its Madeira River ...

Canary Gold Flags Promising Paleochannel Gold System at Brazil’s Madeira River Project

An announcement from Platzer Fastigheter Holding AB ( ($SE:PLAZ.B) ) is now available. Platzer Fastigheter Holding AB’s 2026 Annual General Meeting...

Platzer AGM Approves Dividend, New Board Mandates and Expanded Capital Flexibility

Avanza Bank Holding AB ( ($SE:AZA) ) has shared an update. Avanza Bank Holding AB has called shareholders to its 2026 Annual General Meeting, to be...

Avanza Bank Calls 2026 AGM, Expands Postal Voting Options for Shareholders

The latest announcement is out from Avanza Bank Holding AB ( ($SE:AZA) ). Avanza’s board is asking shareholders at the 28 April 2026 AGM to approve...

Avanza Plans Share-Funded Buyback of Employee Warrants to Limit Dilution

Waters ( ($WAT) ) has provided an update. On March 23, 2026, Augusta SpinCo Corporation, a subsidiary of Waters Corporation, completed a $3.5 billi...

Waters Subsidiary Completes $3.5 Billion Senior Notes Offering

An update from Azitra Inc ( ($AZTR) ) is now available. On March 18, 2026, Azitra Inc. entered into a private placement securities purchase agreeme...

Azitra Secures PIPE Financing to Advance Cosmetic Programs

Cazaly Resources Limited ( ($AU:CAZ) ) has provided an update. Cazaly Resources Limited has issued 5,000,000 fully paid ordinary shares under the t...

Cazaly Resources Issues 5 Million Shares Under Secondary Trading Exemption

An announcement from Cazaly Resources Limited ( ($AU:CAZ) ) is now available. Cazaly Resources Limited has applied for quotation on the ASX of 5,00...

Cazaly Seeks ASX Quotation for 5 Million New Shares Under Finder’s Fee Deal

These are the upcoming stock splits for the week of March 23 to March 27, based on TipRanks’ Stock Splits Calendar. A stock split is a market event...

Upcoming Stock Splits This Week (March 23 to March 27) – Stay Invested

Traders seeking the top stock market stories will want to check out our daily wrap-up for Friday.


Morning News Wrap-Up 3/20/26: Today’s Biggest Market Stories!

AstraZeneca plc ($GB:AZN) announced an update on their ongoing clinical study. AstraZeneca’s new China study takes a close look at how different la...

AstraZeneca’s Pan-HER2 China Study Builds a Quiet Long-Term Edge in Oncology

Azitra Inc stock climbed on Friday after the company revealed details of a private placement.


Why Is Azitra Inc Stock (AZTR) Up Today?

CBL & Associates Properties ( ($CBL) ) has provided an announcement. On March 13, 2026, CBL & Associates’ operating partnership and certain subsidi...

CBL & Associates Announces New $425 Million Loan

AstraZeneca plc ($GB:AZN) announced an update on their ongoing clinical study. The REVIVE study, formally titled “Biomarker-Directed Treatment in P...

AstraZeneca’s REVIVE Trial Targets Relapse After Osimertinib, Extending the Lung Cancer Playbook

AstraZeneca plc ($GB:AZN) announced an update on their ongoing clinical study. AstraZeneca Backs Real-World Kidney Study in China The study, titled...

AstraZeneca Expands Real-World Push With New China Kidney Registry

Piper Sandler analyst David Amsellem reiterated a Buy rating on Jazz Pharmaceuticals today and set a price target of $232.00. According to TipRanks...

Piper Sandler Remains a Buy on Jazz Pharmaceuticals (JAZZ)

In a report released yesterday, Richard Nguyen from Bernstein reiterated a Buy rating on Capgemini SE, with a price target of €208.00. The company’...

Bernstein Sticks to Their Buy Rating for Capgemini SE (0HAZ)

In a report released on March 17, Laurent Daure from Kepler Capital maintained a Buy rating on Capgemini SE, with a price target of €175.00. The co...

Capgemini SE (0HAZ) Gets a Buy from Kepler Capital

Arizona Silver Exploration ( ($TSE:AZS) ) has issued an announcement. Arizona Gold & Silver Inc. has secured a binding CDN$18 million investment fr...

Arizona Gold & Silver Secures $18 Million Above-Market Financing for Philadelphia Project Expansion

AstraZeneca ($~AZN) announced an update on their ongoing clinical study. AstraZeneca’s EXACOS EG Population study, officially titled “Exacerbations...

AstraZeneca Halts Egyptian COPD Burden Study, Trimming Near-Term Data Upside

AstraZeneca plc ($GB:AZN) announced an update on their ongoing clinical study. The study “A Study to Evaluate the Accuracy of Primary Care Diagnosi...

AstraZeneca Advances Primary Care Lung Diagnosis Study With Global Reach

Antipa Minerals Limited ( ($AU:AZY) ) has shared an announcement. Antipa Minerals has released an investor presentation highlighting its dominant 1...

Antipa Highlights Minyari Dome as Core Asset in Paterson Province Portfolio

Plaza Retail REIT ( ($TSE:PLZ.UN) ) has provided an update. Plaza Retail REIT declared a monthly cash distribution for March 2026 of $0.02333 per u...

Plaza Retail REIT Declares March 2026 Monthly Distribution

The latest update is out from Avanza Bank Holding AB ( ($SE:AZA) ). Avanza’s Nomination Committee has proposed that the Board of Directors remain a...

Avanza Nominates Unchanged Board and Leadership Ahead of 2026 AGM

There’s a lot to be optimistic about in the Consumer Cyclical sector as 2 analysts just weighed in on Aristocrat Leisure (ARLUF – Research Report) ...

Analysts Offer Insights on Consumer Cyclical Companies: Aristocrat Leisure (OtherARLUF) and AutoZone (AZO)

The latest update is out from Azincourt Uranium ( ($TSE:AAZ) ). Azincourt Energy Corp. has closed a non-brokered private placement raising approxim...

Azincourt Energy Raises C$2.2 Million to Advance Uranium Exploration

Azitra Inc ( ($AZTR) ) has provided an update. Azitra Inc., a clinical-stage biopharmaceutical company specializing in precision dermatology, is de...

Azitra Faces NYSE American Noncompliance and Delisting Risk

AstraZeneca ($~AZN) announced an update on their ongoing clinical study. The study LYNPARZA Tablets 100mg, 150mg General Drug Use-results Study tra...

AstraZeneca’s Lynparza Safety Study in Japan: What the Latest Update Signals for AZN Investors

Aurizon Holdings ( ($AU:AZJ) ) has provided an announcement. Aurizon Holdings has provided an updated notification to the ASX on progress under its...

Aurizon Updates Market on Progress of On‑Market Share Buy‑Back

The wealth of the Tesla CEO dwarfs other billionaires. 


Elon Musk Is Close to Becoming the World’s First Trillionaire as His Net Worth Hits $839 Billion

AstraZeneca plc ($GB:AZN) announced an update on their ongoing clinical study. The DURGA-4 study, formally titled “A Phase III Open-label, Randomis...

AstraZeneca’s DURGA-4 CAR-T Study Puts New Pressure on Multiple Myeloma Rivals

AstraZeneca plc ($GB:AZN) announced an update on their ongoing clinical study. AstraZeneca study tracks how two versions of its asthma drug move th...

AstraZeneca Advances Pediatric Symbicort Device Study, Supporting Long Term Respiratory Strategy

Cazaly Resources Limited ( ($AU:CAZ) ) just unveiled an announcement. Cazaly Resources Limited has issued 3,333,334 fully paid ordinary shares, fol...

Cazaly Resources Clears Secondary Trading for New Share Issue

Cazaly Resources Limited ( ($AU:CAZ) ) has shared an update. Cazaly Resources Limited has applied for quotation on the ASX of 3,333,334 new fully p...

Cazaly Resources Seeks ASX Quotation for 3.33 Million New Shares

Aurizon Holdings ( ($AU:AZJ) ) just unveiled an update. Aurizon Holdings has provided an updated notification to the market regarding its ongoing o...

Aurizon Continues On-Market Share Buy-Back With Latest Daily Update

Cazaly Resources Limited ( ($AU:CAZ) ) has provided an update. Cazaly Resources Limited has released its consolidated half-year financial report fo...

Cazaly Resources issues consolidated half-year financial report for 2025

Value stocks are shares of companies that appear undervalued relative to their fundamentals. This means their stock price looks low compared with w...

3 Best Value Stocks with Over 10% Upside in 2026, According to Analysts 

The latest announcement is out from Aztec Minerals ( ($TSE:AZT) ). Aztec Minerals has expanded its ongoing drill program at the Tombstone Project i...

Aztec Minerals Expands Tombstone Drilling and Launches Geophysical Surveys

AstraZeneca ($~AZN) announced an update on their ongoing clinical study. The study Understanding Non-small Cell Lung Cancer Patient Characteristics...

AstraZeneca Wraps Real-World Lung Cancer Study, Sharpening Market Insight for AZN Investors

AstraZeneca ($~AZN) announced an update on their ongoing clinical study. The study “Specific Use-results Study of IMJUDO Intravenous Infusion 25 mg...

AstraZeneca Completes Key Japan Safety Study for Imfinzi/Imjudo in Liver Cancer

PROG Holdings ( ($PRG) ) has issued an announcement. On March 10, 2026, PROG Holdings updated its full-year 2026 outlook, narrowing revenue guidanc...

PROG Holdings Updates 2026 Outlook After Purchasing Power Acquisition

Cazaly Resources Limited ( ($AU:CAZ) ) has shared an announcement. Cazaly Resources has released a presentation outlining general information about...

Cazaly Resources Outlines Competent Person-Endorsed Resource Data and Limits on Historical Results

Investors seeking the top stock market stories for Monday will want to check out the daily wrap-up.


Morning News Wrap-Up 3/9/26: Monday’s Biggest Stock Market Stories!

Autozi Internet Technology (NASDAQ:AZI) shares skyrocketed over 200% today after the Chinese automotive services and supply-chain company unveiled ...

Why Autozi Internet Technology Stock (AZI) Jumped Today and What to Expect Next

The latest update is out from Atea ASA ( ($ATAZF) ). Atea ASA has continued its previously announced share buyback program, which runs from August ...

Current Yield	N/A	Payout Ratio	N/A
Annual DPS	$0.00	Growth Streak	0 years
Ex-Dividend	Invalid Date	Pay Date	Invalid Date
Record Date	N/A	Declaration	N/A
Frequency	NA	Quarterly Est	$0.00

	A	B	C	D
1	Symbol	Price	Change	Volume
2	AZ	$8.16	-1.09%	523.97K
3
4
5

	A	B	C	D
1	Symbol	Price	Change	Vol
2	AZ	$8.16	-1.1%	523.97K
3
4
5
6

AZ

AZ

Dividend Overview

Get A2Z Cust2Mate Solutions Corp. Data in Excel

Get A2Z Cust2Mate Solutions Corp. Data in Excel